|Bid price||1,417.00||Open price||1,436.00|
|Ask price||1,422.00||Prev close||1,422.00|
Register now for FREE live Dechra Pharmaceuticals share prices, Dechra Pharmaceuticals stock quotes, charts, trades market news and much much more. Why not upgrade to a premium service and get Dechra Pharmaceuticals Level 2 Data, indepth research tools and investor commentary for Dechra Pharmaceuticals (DPH) and other London Stock Exchange equities.
Register now for FREE Dechra Pharmaceuticals share price charts
|Sector||Pharmaceuticals & Biotechnology||ISIN||GB0009633180|
|Activites||Dechra Pharmaceuticals plc is an international veterinary pharmaceutical business. Its expertise is in the development, manufacturing, distribution, sales and marketing of high quality products exclusively for veterinarians worldwide. Dechra's business is unique as the majority of its products are used to treat medical conditions for which there is no other effective solution or have a clinical or dosing advantage over competitor products.||Index||FTSE 250|
|Latest Share Price (p)||1,419.50||Net Gearing (%)||43.69|
|Market Capitalisation (£m)||1,339.02||Gross Gearing (%)||50.67|
|Shares in issue (m)||93.05||Debt Ratio||44.06|
|P/E Ratio||102.79||Debt-to-Equity Ratio||0.77|
|Total dividends per share (p)||18.46||Assets / Equity Ratio||2.03|
|Dividend Yield (%)||1.28||Price to book value||4.84|
|Dividend cover (x)||1.25||ROCE (%)||2.94|
|Earning per share (p)||14.00||EPS Growth (%)||-36.77|
|52 week high / low||1,495.00 / 811.00||DPS Growth (%)||8.97|
|Dec.Date||Type||Director||Pos||No. of Shares|
Dechra Pharmaceuticals says reported group revenue for the six months to the end of December increased by approximately 34% at constant exchange rate (56% at actual exchange rate). Core group revenue growth, excluding the benefit from acquisitions, was 7% at CER (AER 22%); growth in the core...
Story provided by StockMarketWire.com
RNS Number : 3016U Dechra Pharmaceuticals PLC 17 January 2017 Tuesday, 17 January 2017 Dechra® Pharmaceuticals PLC ("Dechra" or "the Company ") Trading Update The Board of Dechra issues the following unaudited Trading Update...
Register now for FREE Dechra Pharmaceuticals company news
A really dreary share! Dechra Pharmaceuticals manufactures and distributes vetinary products and equiptment.Has a few own brands:- Equipalazone,Vetoryl and Felimazole -anyone used them? My stockbroker molested me so much over this company that I finally bought at 130p,(Feb 04); now at 182.5p and...
Register now for FREE Dechra Pharmaceuticals share price discussions